“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Saturday, August 30, 2025

Aytu BioScience


Aytu BioScience products

A

  • ADZENYS XR-ODT – Extended-release orally disintegrating tablet for the treatment of ADHD in patients aged 6 years and older.

C

  • COTEMPLA XR-ODT – Extended-release orally disintegrating tablet for the treatment of ADHD in patients aged 6 to 17 years.

E

  • EXXUA – For major depressive disorder (MDD) in adults.

G

  • GLOPERBA – (No entry)

K

  • Karbinal ER – Extended-release carbinoxamine suspension for treatment of allergic conditions in patients aged 2 and older.

M

  • METADATE CD – Extended-release methylphenidate capsule for the treatment of ADHD in patients aged 6 to 15 years.

  • MiOXSYS – Semen analysis system measuring oxidative stress; marketed outside the U.S. with plans for U.S. FDA clearance.

N

  • Natesto – Nasal gel formulation of testosterone for treating male hypogonadism (low T).

P

  • Poly-Vi-Flor – Fluoride and vitamin liquid formulation for infants and children to treat/prevent fluoride deficiency.

  • Prenatal Supplements – (No entry)

T

  • Tri-Vi-Flor – Fluoride and vitamin chewable tablet for infants and children to treat/prevent fluoride deficiency.

  • Tuzistra XR – Extended-release codeine + chlorpheniramine oral suspension for cough relief; previously marketed (now discontinued).

  • ZolpiMist – Oral spray formulation of zolpidem for short-term insomnia treatment.




on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)